Jenna Smith

Jenna Smith

Auto-generated profile, based on publicly available information

Jenna Smith

Sydney Health Literacy Lab, Sydney School of Public Health, Faculty of Medicine and Health The University of Sydney Sydney New South Wales Australia

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2021 in Medical Decision Making
Verified
Journal Article
Closed access
PDF file
DMDanielle M. Muscat
Danielle M. Muscat
JSJenna Smith
Jenna Smith
OMOlivia Mac
Olivia Mac
TCTamara Cadet
Tamara Cadet
AGAnik Giguere
Anik Giguere
KMKirsten McCaffery
Kirsten McCaffery
Background: There is increasing recognition of the importance of addressing health literacy in patient decision aid (PtDA) development. Purpose: An updated review as part of IPDAS 2.0 examined the extent to which PtDAs are designed to meet the needs of people with low health literacy/socially-disadvantaged populations. Data Sources: Reference lists of Cochrane reviews of randomized controlled trials (RCTs) of PtDAs (2014, 2017, and upcoming 2021 versions). Study Selection: RCTs that assessed the impact of PtDAs on low health literacy or other socially-disadvantaged groups (i.e., ≥50% participants from socially-disadvantaged groups and/or subgroup analysis in socially-disadvantaged group/s). Data Extraction: Two researchers independently extracted data into a standardized form including PtDA development and evaluation details. We searched online repositories and emailed authors to access PtDAs to verify grade reading level, understandability, and actionability. Data Synthesis: Twenty-five of 213 RCTs met the inclusion criteria, illustrating that only 12% of studies addressed the needs of low health literacy or other socially-disadvantaged groups. Grade reading level was calculated in 8 of 25 studies (33%), which is recommended in previous IPDAS guidelines. We accessed and independently assessed 11 PtDAs. None were written at sixth-grade level or below. Ten PtDAs met the recommended threshold for understandability, but only 5 met the recommended threshold for actionability. We also conducted a post hoc subgroup meta-analysis and found that knowledge improvements after receiving a PtDA were greater in studies that reported using strategies to reduce cognitive demand in PtDA development compared with studies that did not (χ2 = 14.11, P = 0.0002, I2 = 92.9%). Limitations: We were unable to access 13 of 24 PtDAs. Conclusions. Greater attention to health literacy and socially-disadvantaged populations is needed in the field of PtDAs to ensure equity in decision support.

21 June 2021 in Medical Decision Making
Verified
Journal Article
Closed access
PDF file
RYRenata W. Yen
Renata W. Yen
JSJenna Smith
Jenna Smith
JEJaclyn Engel
Jaclyn Engel
DMDanielle Marie Muscat
Danielle Marie Muscat
SSSian K. Smith
Sian K. Smith
MDMarie-Anne Durand
Marie-Anne Durand
Background: The effectiveness of patient decision aids (PtDAs) and other shared decision-making (SDM) interventions for socially disadvantaged populations has not been well studied. Purpose: To assess whether PtDAs and other SDM interventions improve outcomes or decrease health inequalities among socially disadvantaged populations and determine the critical features of successful interventions. Data Sources: MEDLINE, CINAHL, Cochrane, PsycINFO, and Web of Science from inception to October 2019. Cochrane systematic reviews on PtDAs. Study Selection: Randomized controlled trials of PtDAs and SDM interventions that included socially disadvantaged populations. Data Extraction: Independent double data extraction using a standardized form and the Template for Intervention Description and Replication checklist. Data Synthesis: Twenty-five PtDA and 13 other SDM intervention trials met our inclusion criteria. Compared with usual care, PtDAs improved knowledge (mean difference = 13.91, 95% confidence interval [CI] 9.01, 18.82 [I2 = 96%]) and patient-clinician communication (relative risk = 1.62, 95% CI 1.42, 1.84 [I2 = 0%]). PtDAs reduced decisional conflict (mean difference = −9.59; 95% CI −18.94, −0.24 [I2 = 84%]) and the proportion undecided (relative risk = 0.39; 95% CI 0.28, 0.53 [I2 = 75%]). PtDAs did not affect anxiety (standardized mean difference = 0.02, 95% CI −0.22, 0.26 [I2 = 70%]). Only 1 trial looked at clinical outcomes (hemoglobin A1C). Five of the 12 PtDA studies that compared outcomes by disadvantaged standing found that outcomes improved more for socially disadvantaged participants. No evidence indicated which intervention characteristics were most effective. Results were similar for SDM intervention trials. Limitations: Sixteen PtDA studies had an overall unclear risk of bias. Heterogeneity was high for most outcomes. Most studies only had short-term follow-up. Conclusions: PtDAs led to better outcomes among socially disadvantaged populations but did not reduce health inequalities. We could not determine which intervention features were most effective. [Box: see text]

8 November 2021 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
JSJenna Smith
Jenna Smith
RDRachael H. Dodd
Rachael H. Dodd
KGKaren M. Gainey
Karen M. Gainey
VNVasi Naganathan
Vasi Naganathan
ECErin Cvejic
Erin Cvejic
KMKirsten J. McCaffery
Kirsten J. McCaffery
Decisions for older adults (aged ≥65 years) and their clinicians about cancer screening are not easy. The evidence of benefits is unclear and the chance of harm becomes greater (eg, overdiagnosis, burdens of additional testing, false-positive results, and psychological impacts),1-3 which can adversely impact an older individual’s remaining quality of life.4-7 Although guidelines recommend when screening is no longer needed (eg, life expectancy <10 years for breast screening),8 many older people with limited life expectancy continue screening for colorectal, breast, cervical, and prostate cancer.9,10

27 October 2022 in The Patient - Patient-Centered Outcomes Research
Verified
Journal Article
Open access
PDF file
KGKaren M. Gainey
Karen M. Gainey
JSJenna Smith
Jenna Smith
KMKirsten J. McCaffery
Kirsten J. McCaffery
SCSharon Clifford
Sharon Clifford
DMDanielle Muscat
Danielle Muscat
Background Plain language summaries (PLSs) are intended for a non-expert audience in order to make health research accessible and understandable to the public. This is important because most research is written with jargon and at a high reading level. However, there is a high degree of variability in the instructions for writing PLSs, which may impede their usefulness as a tool for communicating health research to the public. Objective The aim of this scoping review was to conduct a detailed analysis of the author instructions for PLSs provided by leading biomedical and health journals. Method We screened 534 health journals covering 11 categories selected from the InCites Journal Citation Reports linked to the top 10 non-communicable diseases. We included journals published in English that recommended the inclusion of a PLS (as defined by the National Institute for Health Research) and provided authors with text-based instructions on how it should be written. Two independent reviewers extracted data pertaining to common elements identified in author instructions, such as word count/PLS length, content, structure, purpose, wording to support plain language, and the use of jargon, acronyms and abbreviations. Other aspects of PLSs were recorded, such as the label used (e.g., plain language summary, lay summary, and patient summary), journal publisher, consumer involvement and whether the PLS is optional or mandatory. We recorded the frequency of each element and qualitative details of specific instructions. A consumer representative provided ongoing and iterative feedback on the methods, results, and reporting of this study Results Despite reviewing 534 journals across 10 non-communicable disease areas and 11 journal categories, we found only 27 (5.1%) contained text-based instructions for PLS. Of the 27 journals included in this review, most (70%) did not require a PLS. Approximately 70% of journals with PLS instructions included advice about the use of jargon, abbreviations, and acronyms. Only one journal recommended the use of a readability tool, however five noted that the reading level of the audience or readability of the PLS should be considered. Author instructions were highly heterogeneous between journals. There was inconsistency regarding the word count/PLS length (e.g., between 100 and 850 words), structure (e.g., paragraphs or bullet points), and varying levels of detail for other elements in the instructions. Although only one journal recommended consumer involvement in the development of PLSs, many recommended authors consult those who are not an expert in their field to review their summary prior to submission. Conclusion The development of consistent author instructions could enhance the effectiveness and use of PLSs. Such instructions should be developed with consumers to ensure they met the needs of a lay non-expert audience.

22 August 2024 in BMJ Quality & Safety
Verified
Journal Article
Open access
PDF file
DMDanielle Muscat
Danielle Muscat
ECErin Cvejic
Erin Cvejic
JSJenna Smith
Jenna Smith
RTRachel Thompson
Rachel Thompson
ECEdward Chang
Edward Chang
KMKirsten McCaffery
Kirsten McCaffery
Objective: To (a) examine whether the effect of the Choosing Wisely consumer questions on question-asking and shared decision-making (SDM) outcomes differs based on individuals’ health literacy and (b) explore the relationship between health literacy, question-asking and other decision-making outcomes in the context of low value care. Methods: Preplanned analysis of randomised trial data comparing: the Choosing Wisely questions, a SDM video, both interventions or control (no intervention). Randomisation was stratified by participant health literacy (‘adequate’ vs ‘limited’), as assessed by the Newest Vital Sign. Main outcome measures: Self-efficacy to ask questions and be involved in decision-making, and intention to engage in SDM. Participants: 1439 Australian adults, recruited online. Results: The effects of the Choosing Wisely questions and SDM video did not differ based on participants’ health literacy for most primary or secondary outcomes (all two-way and three-way interactions p>0.05). Compared with individuals with ‘adequate’ health literacy, those with ‘limited’ health literacy had lower knowledge of SDM rights (82.1% vs 89.0%; 95% CI: 3.9% to 9.8%, p<0.001) and less positive attitudes towards SDM (48.3% vs 58.1%; 95% CI: 4.7% to 15.0%, p=0.0002). They were also more likely to indicate they would follow low-value treatment plans without further questioning (7.46/10 vs 6.94/10; 95% CI: 0.33 to 0.72, p<0.001) and generated fewer questions to ask a healthcare provider which aligned with the Choosing Wisely questions (χ2 (1)=73.79, p<.001). On average, 67.7% of participants with ‘limited’ health literacy indicated that they would use video interventions again compared with 55.7% of individuals with ‘adequate’ health literacy. Conclusion: Adults with limited health literacy continue to have lower scores on decision-making outcomes in the context of low value care. Ongoing work is needed to develop and test different intervention formats that support people with lower health literacy to engage in question asking and SDM.

11 June 2020 in BMJ Open
Verified
Journal Article
Open access
PDF file
JSJenna Smith
Jenna Smith
Rachael DoddRachael Dodd
Rachael Dodd
JHJolyn Hersch
Jolyn Hersch
ECErin Cvejic
Erin Cvejic
KMKirsten McCaffery
Kirsten McCaffery
JJJesse Jansen
Jesse Jansen
Objective To assess different strategies for communicating to older adults about stopping cancer screening. Design 4 (recommendation statement about stopping screening)×(2; time) online survey-based randomised controlled trial. Setting Australia. Participants 271 English-speaking participants, aged 65–90, screened for breast/prostate cancer at least once in past decade. Interventions Time 1: participants read a scenario in which their general practitioner (GP) informed them about the potential benefits and harms of cancer screening, followed by double-blinded randomisation to one of four recommendation statements to stop screening: control (‘this screening test would harm you more than benefit you’), health status (‘your other health issues should take priority’), life expectancy framed positively (‘this test would not help you live longer’) and negatively (‘you may not live long enough to benefit’). Time 2: in a follow-up scenario, the GP explained why guidelines changed over time (anchoring bias intervention). Measures Primary outcomes: screening intention and cancer anxiety (10-point scale, higher=greater intention/anxiety), measured at both time points. Secondary outcomes: trust (in their GP, the information provided, the Australian healthcare system), decisional conflict and knowledge of the information presented. Results 271 participants’ responses analysed. No main effects were found. However, screening intention was lower for the negatively framed life expectancy versus health status statement (6.0 vs 7.1, mean difference (MD)=1.1, p=0.049, 95% CI 0.0 to 2.2) in post hoc analyses. Cancer anxiety was lower for the negatively versus positively framed life expectancy statement (4.8 vs 5.8, MD=1.0, p=0.025, 95% CI 0.1 to 1.9). The anchoring bias intervention reduced screening intention (MD=0.8, p=0.044, 95% CI 0.6 to 1.0) and cancer anxiety (MD=0.3, p=0.002, 95% CI 0.1 to 0.4) across all conditions. Conclusion Older adults may reduce their screening intention without reporting increased cancer anxiety when clinicians use a more confronting strategy communicating they may not live long enough to benefit and add an explicit explanation why the recommendation has changed. Trial registration number Australian New Zealand Clinical Trials Registry (ACTRN12618001306202; Results).